Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2020

01-12-2020 | SCLC | Case report

Cisplatin/etoposide

Haemoptysis, respiratory failure and acute coronary disease: 3 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Metadata
Title
Cisplatin/etoposide
Haemoptysis, respiratory failure and acute coronary disease: 3 case reports
Publication date
01-12-2020
Publisher
Springer International Publishing
Keywords
SCLC
SCLC
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-87551-y

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Carbamazepine

Case report

Doxorubicin/ethiodized-oil/mitomycin

Case report

Pazopanib

Case report

Heparin

Case report

Epinephrine

News item

Health Canada mitigating risks of bacitracin injection-related reactions